Sitryx advances development of PKM2 modulator SYX-5219 into atopic dermatitis patients following clinical evidence of ...
The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...
Genentech's native HIC-MS method uses ammonium tartrate, enabling efficient MS detection without compromising chromatographic ...
Nocion Therapeutics, Inc. a biopharmaceutical company developing novel small molecule therapies that selectively silence activated sensory neurons, today announced that preclinical data supporting the ...
Cell division is a fundamental process that allows cells to replicate accurately and maintain tissue homeostasis. This ...
Waldorf synthesizers have a good reputation for their sound. The Protein establishes a new device class at a smaller price.
CML Micro has launched the CMX918, an advanced, ultra-low-power, multi-mode Software-Defined Radio (SDR) tuner designed to significantly extend battery life in portable, embedded, and always-on radio ...
Data update from the ongoing Phase 1b/2 study of muzastotug + pembrolizumab in 3L+ MSS CRC patients remains on track for Q1 ...
Company expands its ADC pipeline and patent estate for novel, differentiated ADCsNew pipeline candidate AKTX-102 leverages ...
A new smart city near Stellenbosch is progressing with infrastructure, industry and residential plans already underway.
An estimated 60% of patients with Alzheimer's disease develop epilepsy or subclinical epileptiform activity over the course of the disease. New-onset seizures in cognitively healthy adults also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results